Health Care & Life Sciences » Pharmaceuticals | China Shineway Pharmaceutical Group Ltd.

China Shineway Pharmaceutical Group Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,760
2,806
2,535
2,329
2,213
3,044
Cost of Goods Sold (COGS) incl. D&A
899
945
856
826
752
822
Gross Income
1,860
1,860
1,679
1,503
1,461
2,222
SG&A Expense
990
978
921
843
990
1,635
EBIT
871
882
758
682
471
587
Non Operating Income/Expense
142
158
161
53
59
112
Interest Expense
-
4
21
-
-
-
Pretax Income
1,085
1,087
983
812
678
793
Income Tax
222
200
172
124
157
193
Consolidated Net Income
863
887
811
688
521
599
Net Income
863
887
812
688
521
599
Net Income After Extraordinaries
863
887
812
688
521
599
Net Income Available to Common
863
887
812
688
521
599
EPS (Basic)
1.05
1.07
0.99
0.83
0.63
0.73
Basic Shares Outstanding
827
827
827
827
827
816
EPS (Diluted)
1.04
1.07
0.98
0.83
0.63
0.73
Diluted Shares Outstanding
827
827
827
827
827
818
EBITDA
999
1,063
958
905
523
636
Other Operating Expense
-
-
-
22
-
-
Non-Operating Interest Income
75
69
64
77
62
93
Minority Interest Expense
-
-
-
-
-
-
Equity in Affiliates (Pretax)
1
-
-
-
-
-

About China Shineway Pharmaceutical Group

View Profile
Address
Luan Cheng
Shijiazhuang Hebei 051430
China
Employees -
Website http://www.shineway.com
Updated 07/08/2019
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. Its products include Shen Mai injection, Qing Kai Ling injection, and Wu Fu Xin Nao Qing soft capsule. The company was founded by Zhen Jiang Li and Yun Xia Xin on August 14, 2002 and is headquartered in Shijiazhuang, China.